Position in AZN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$446,555
-$22,236 QoQ
Shares Held
2,355
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#893
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADVISORS MANAGEMENT GROUP INC /ADV holds $7,828,853 across 8 Drug Manufacturers - General names. AZN ranks #2 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,144 | $5,623,911 | |
| 2 | AZN |
Astrazeneca PLC
This page
|
2,355 | $446,555 | |
| 3 | NVS |
Novartis AG
|
2,167 | $339,612 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,579 | $331,401 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
5,643 | $325,149 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,521 | $318,503 | |
| 7 | GSK |
GSK plc
|
4,634 | $242,914 | |
| 8 | ABBV |
AbbVie Inc.
|
798 | $200,808 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $446,555 | 2,355 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $468,791 | 2,377 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||